Skip to content
Fiscal Receipts

Senate LDA lobbying filing

Cencora, Inc.

A public disclosure record: who filed, what they reported, and the program connections found in the text.
Registrant: Brownstein Hyatt Farber Schreck, LLP Year: 2025 Period: Third Quarter Type: Q3

Filed as: CENCORA, INC. — BROWNSTEIN HYATT FARBER SCHRECK, LLP. Search lda.senate.gov for those strings; the names above are this site’s casing of them, nothing else.

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Connections in the record

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities2

  • Health IssuesHCR

    IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).

  • PharmacyPHA

    Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.

Lobbyists6

  • ADAM STEINMETZ
  • DEEMA TARAZI
  • EMILY FELDER
  • GREGORY SUNSTRUM
  • LAUREN MISH
  • ZACHARY PFISTER

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.